Clinical Trials on Enlarged Prostate
Total 6907 results
-
CureVacCompletedHormonal Refractory Prostate CancerGermany, Italy
-
Burzynski Research InstituteWithdrawnStage IV Prostate CancerUnited States
-
Tianjin Medical University Cancer Institute and...Peking University First Hospital; The Affiliated Nanjing Drum Tower Hospital... and other collaboratorsUnknownStage IV Prostate CancerChina
-
US Oncology ResearchEli Lilly and Company; Oregon Health and Science UniversityCompletedAndrogen-independent Prostate CancerUnited States
-
Mary-Ellen Taplin, MDSanofi; Beth Israel Deaconess Medical Center; Genentech, Inc.; Duke UniversityCompletedProstate Cancer | Adenocarcinoma of the ProstateUnited States
-
Temple UniversityCompleted
-
ExelixisTerminatedProstatic Neoplasms | Prostate Cancer | Castration Resistant Prostate CancerUnited States
-
Infinity Pharmaceuticals, Inc.CompletedProstatic Neoplasms | Prostate Cancer | Cancer of the ProstateUnited States
-
AgennixCompletedProstate Cancer | Hormone Refractory Prostate CancerUnited States, United Kingdom, France, Italy, Israel, Germany, Hungary, Argentina, Russian Federation, Belgium, Croatia, Netherlands, Peru, Poland, Spain
-
AstraZenecaCompletedNon-metastatic Prostate CancerUnited States, Canada
-
Veeda OncologyBayerTerminatedHormone Refractory Prostate CancerUnited States
-
Zhengzhou UniversityThe First Affiliated Hospital of Zhengzhou University; Xinyang Central Hospital and other collaboratorsUnknown
-
CytoVac A/SCompletedHormone-refractory Prostate CancerDenmark
-
University of FloridaCureVacTerminated
-
National University Hospital, SingaporeCompletedHormone-Refractory Prostate CancerSingapore
-
CytRxCompletedHormone Refractory Prostate CancerUnited States
-
AstraZenecaCompletedNon-Metastatic Prostate CancerCzech Republic, Italy, South Africa, United Kingdom, Germany, Poland, Netherlands, Austria, Belgium, Hungary, Israel, Portugal, Mexico, Spain, Australia, Ireland
-
Ascenta TherapeuticsCompletedHormone Refractory Prostate CancerUnited States, Russian Federation
-
Merrion Pharmaceuticals, LLCCompletedHormone-Refractory Prostate CancerUnited States, Estonia, Latvia
-
AstraZenecaNo longer availableAdenocarcinoma of the Prostate
-
Barts & The London NHS TrustTerminatedCastrate Resistant Prostate CancerUnited Kingdom
-
AstraZenecaCompletedCastration-resistant Prostate CancerBrazil, Peru, Mexico, Argentina, Costa Rica, Colombia, Panama
-
Technische Universität DresdenCompletedProstate Cancer | Oligometastatic DiseaseGermany
-
Brown UniversityAstraZeneca; The Miriam Hospital; Rhode Island HospitalTerminatedProstate Cancer | Adenocarcinoma of the ProstateUnited States
-
Modra PharmaceuticalsThe Netherlands Cancer InstituteCompletedCastration-resistant Prostate CancerNetherlands
-
Taro Iguchi, MD, PHDAstellas Pharma IncCompleted
-
Jiangsu HengRui Medicine Co., Ltd.TerminatedProstate Cancer | Castration-resistant Prostate CancerChina
-
SOTIO a.s.TerminatedCastration-resistant Prostate CancerCzechia
-
Novartis PharmaceuticalsCompletedCastration Resistant Prostate CancerGermany
-
Novartis PharmaceuticalsTerminatedHormone Refractory Prostate CancerUnited States
-
Novartis PharmaceuticalsCompletedCastration-resistant Prostate CancerFrance, Spain, Canada, Belgium, United Kingdom, United States
-
Momotaro-Gene Inc.The Pacific Link Consulting CoCompletedLocalized Prostate CancerUnited States
-
CelgeneCompletedHormone Refractory Prostate CancerUnited States
-
Bellicum PharmaceuticalsCompletedCastrate Resistent Prostate CancerUnited States
-
Institut Paoli-CalmettesJanssen-Cilag Ltd.UnknownLow Risk Prostate CancerFrance
-
Georgetown UniversityTerminatedStage II Prostate CarcinomaUnited States
-
Charles RyanNovartis PharmaceuticalsTerminatedCastrate-resistant Prostate CancerUnited States
-
University Health Network, TorontoCompletedStudy of Antioxidants on Prostate Tumors in Men Undergoing Radical Prostatectomy for Prostate CancerProstatic Neoplasms | Prostate Cancer | Cancer of the ProstateCanada
-
Queen's Medical CenterNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedHormone Refractory Prostate CancerUnited States
-
Spanish Oncology Genito-Urinary GroupCompleted
-
Memorial Sloan Kettering Cancer CenterCompletedCancer | Prostate | Hormonal CyclingUnited States
-
Daniel George, MDNovartis PharmaceuticalsCompletedHormone Refractory Prostate CancerUnited States
-
University of ChicagoVisualase, Inc.Completed
-
Astellas Pharma IncTerminatedCastrate Resistant Prostate CancerBelgium, France, United Kingdom
-
Veterans Medical Research FoundationUniversity of California, San Diego; Alliant International UniversityCompleted
-
GenVecNational Institutes of Health (NIH)UnknownLocally Advanced Prostate CancerUnited States
-
DendreonCompletedHormone-Refractory Prostate Cancer
-
Medical University of ViennaUnknownHormone Refractory Prostate CancerAustria
-
Sheba Medical CenterUnknownHormone Refractory Prostate CancerIsrael
-
AstraZenecaScandinavian Prostate Cancer GroupCompletedNon-Metastatic Prostate CancerSweden, Finland, Norway, Denmark